BR9303733A - Uso,de um composto,substancia ou composicao,na preparacao de uma substancia ou composicao para tratar uma infeccao viral,composto,substancia ou composicao,respectivos usos para,tratamento de uma infeccao viral,como remedio ou medicamento,como agente terapeutico ativo no tratamento de uma infeccao viral;remedio ou medicamento,processo de preparar um composto e processo de tratar uma infeccao viral num ser humano ou animal - Google Patents

Uso,de um composto,substancia ou composicao,na preparacao de uma substancia ou composicao para tratar uma infeccao viral,composto,substancia ou composicao,respectivos usos para,tratamento de uma infeccao viral,como remedio ou medicamento,como agente terapeutico ativo no tratamento de uma infeccao viral;remedio ou medicamento,processo de preparar um composto e processo de tratar uma infeccao viral num ser humano ou animal

Info

Publication number
BR9303733A
BR9303733A BR9303733A BR9303733A BR9303733A BR 9303733 A BR9303733 A BR 9303733A BR 9303733 A BR9303733 A BR 9303733A BR 9303733 A BR9303733 A BR 9303733A BR 9303733 A BR9303733 A BR 9303733A
Authority
BR
Brazil
Prior art keywords
viral infection
substance
compound
composition
medicine
Prior art date
Application number
BR9303733A
Other languages
English (en)
Inventor
Roelof Wilke Liebenberg
Petrus Buys Kruger
Patrick Jacques Desire Bouic
Carl Franz De Vos Albrecht
Original Assignee
Virostat Na N V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virostat Na N V filed Critical Virostat Na N V
Publication of BR9303733A publication Critical patent/BR9303733A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225Polycarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/205Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings
    • C07C39/21Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings with at least one hydroxy group on a non-condensed ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • C07H1/06Separation; Purification
    • C07H1/08Separation; Purification from natural products
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/203Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR9303733A 1992-09-07 1993-09-08 Uso,de um composto,substancia ou composicao,na preparacao de uma substancia ou composicao para tratar uma infeccao viral,composto,substancia ou composicao,respectivos usos para,tratamento de uma infeccao viral,como remedio ou medicamento,como agente terapeutico ativo no tratamento de uma infeccao viral;remedio ou medicamento,processo de preparar um composto e processo de tratar uma infeccao viral num ser humano ou animal BR9303733A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA926775 1992-09-07
ZA933949 1993-06-04

Publications (1)

Publication Number Publication Date
BR9303733A true BR9303733A (pt) 1994-03-15

Family

ID=66817979

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9303733A BR9303733A (pt) 1992-09-07 1993-09-08 Uso,de um composto,substancia ou composicao,na preparacao de uma substancia ou composicao para tratar uma infeccao viral,composto,substancia ou composicao,respectivos usos para,tratamento de uma infeccao viral,como remedio ou medicamento,como agente terapeutico ativo no tratamento de uma infeccao viral;remedio ou medicamento,processo de preparar um composto e processo de tratar uma infeccao viral num ser humano ou animal

Country Status (10)

Country Link
EP (1) EP0587396A1 (pt)
JP (1) JPH06219974A (pt)
KR (1) KR940006591A (pt)
CN (1) CN1091291A (pt)
AU (1) AU667564B2 (pt)
BR (1) BR9303733A (pt)
CA (1) CA2105630A1 (pt)
IL (1) IL106939A0 (pt)
MX (1) MX9305453A (pt)
ZW (1) ZW11693A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5569649A (en) * 1994-06-14 1996-10-29 Phytopharm (Na) N.V. Anti-inflammatory treatment method
SG11201404361UA (en) * 2012-01-26 2014-09-26 Life Technologies Corp Methods for increasing the infectivity of viruses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2120650A (en) * 1982-04-19 1983-12-07 Roecar Holdings Nv Rooperol derivatives
GB8317850D0 (en) * 1983-06-30 1983-08-03 Roecar Holdings Nv Rooperol and its derivatives
ATE61329T1 (de) * 1985-06-19 1991-03-15 Rooperol Na Nv Verfahren zur herstellung von rooperol, hypoxosid und deren derivaten.

Also Published As

Publication number Publication date
CN1091291A (zh) 1994-08-31
MX9305453A (es) 1994-05-31
KR940006591A (ko) 1994-04-25
CA2105630A1 (en) 1994-03-08
AU667564B2 (en) 1996-03-28
AU4611093A (en) 1994-03-17
EP0587396A1 (en) 1994-03-16
JPH06219974A (ja) 1994-08-09
IL106939A0 (en) 1993-12-28
ZW11693A1 (en) 1994-03-30

Similar Documents

Publication Publication Date Title
TW246641B (pt)
BR9813373A (pt) Composto, processo para a preparação do mesmo, composição farmacêutica, processo para a preparação da mesma, uso de um composto, e, processos para efetuar imunossupressão e para tratar ou reduzir o risco de uma doença das vias aérias obstrutiva reversìvel em um paciente
BR9810745A (pt) Derivados de benzimidazol
SE9401406L (sv) Farmaceutiska produkter för att bota tumörsjukdomar samt förfarande för framställning av desamma
BR8300475A (pt) Composto, composicao farmaceutica, processo para tratamento de infeccao virotica em um animal de sangue quente ou de sangue frio, e processo para a preparacao de tal composto
UA41989C2 (uk) Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
EP0333606A3 (en) Preparation of t-cell and t-cell membrane for use in prevention and treatment of autoimmune diseases
MY117892A (en) Therapeutic compounds
BR9007911A (pt) Concentrado emulsionavel estavel,processo para tratamento de plantas,e de praga em animais,composicao para uso na formacao de concentrado emulsionavel,composicao compreendendo o concentrado emulsionavel,e processo para controle da populacao de pragas agricolas
BR9714063A (pt) Composto, processo para a preparação e uso do mesmo, composição farmacêutica, e, processos para preparação da mesma, para executar a imunossupressão e para tratar ou reduzir o risco de uma doença reversìvel, obstrutiva das vias aéreas
BR9500436A (pt) Produtos uso de um g-csf uso de uma proteína tnf ligante processo para o tratamento e/ou prevenção do choque séptico
BR9007769A (pt) Preparacao para o tratamento de tecido alheio,processo para a preparacao de tecido alheio ex-vivo antes de transplante ou de seu uso como material curativo,processo para o tratamento de um paciente,e,processo para realizacao de transplantes de orgaos alogenicos ou xenogenicos a um paciente humano,ou para fornecimento de curativo alogenico ou xenogenico a este paciente
ES2139578T3 (es) Composiciones y procedimiento para modular la actividad del arn mediante la modificacion de la estructura protectora 5' del arn.
DE59002748D1 (de) Verfahren zur Herstellung von Mitteln zur Therapie von Hauterkrankungen.
ES8400742A1 (es) Procedimiento de preparacion de las dibenzooxepinas sustituidas y de sus sales de adicion con un acido mineral u organi-co.
BR9510015A (pt) Composto composição farmacéutica e processo para o tratamento de doenças enfecciosas em terapia humana ou veterinária
DE69929616D1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
DE69016284D1 (de) Antibiotikum GE 22270, Faktoren A1,A2,A3 und H.
DE69026511D1 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
RU95101900A (ru) Лекарственный препарат для лечения артрита и способ его приготовления
CN1052789A (zh) 一种烧伤药膏的制备方法
BR8901159A (pt) Substancia f-0368 ou um seu sal;processos para produzi-los;composicao;agente preventivo para doencas de plantas;processo para evitar doencas de plantas;desinfetante e materiais para uso em agricultura;processo para cultivar plantas,e microorganismo
ATE66375T1 (de) Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur systemischen behandlung von verschiedenen erkrankungen des menschen in niedriger dosierung.
ATE137968T1 (de) Verwendung von l-2-oxothiazolidine-4-carboxylate zur herstellung eines arzneimittels zur behandlung von latenten hiv-infektionen
CN1284365A (zh) 骨折一帖愈

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
HKFN Application deemed withdrawn (deleted)
FA7 Application withdrawn (art. 18 par. 1 of law 5772/71) - being contrary to morals, good customs and public security, order and health